Skip to main content
Fig. 2 | BMC Pulmonary Medicine

Fig. 2

From: Dapagliflozin, sildenafil and their combination in monocrotaline-induced pulmonary arterial hypertension

Fig. 2

Treatment with dapagliflozin attenuated right ventricular systolic pressure (RVSP) (A) and right ventricular hypertrophy (RVH) (B) in MCT-injected rats (n = 9–10). Values are means ± SD. Comparisons were made by the Student’s t-test. Dapa, dapagliflozin; MCT, Monocrotaline; Veh, vehicle; Silde, sildenafil. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 versus MCT rats treated with vehicle

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us